Published in Law and Health Weekly, July 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Affymetrix Inc..
Report 1: Affymetrix Inc. (NASDAQ:AFFX) and NuGEN Technologies Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems for small and difficult samples, announced their agreement to co-market a solution that enables researchers to access FFPE (formalin-fixed, paraffin-embedded) tissue samples derived from years of clinical studies previously inaccessible by traditional RNA amplification methods. The NuGEN...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.